Recent Updates by Topic
Popular Content
Profs Receive $25M Grant
April 30, 2008 - 12:00amTwo Cornell professors won a $25 million grant for a new interdisciplinary scientific research and education center at Cornell, announced the Global Research Partnership of King Abdullah University of Science and Technology yesterday.
The KAUST-Cornell University Center for Research and Education will be co-led by Prof. Emmanuel Giannelis, materials science and engineering, and Prof. Lynden Archer, chemical and biolomolecular engineering, the Marjorie L. Hart Professor of Engineering. Giannelis and Archer’s proposal is selected as one of the four winners among the 41 initial applications submitted in late 2007.
Profs Granted $1 Million for Research
April 29, 2008 - 12:00amThe Hartwell Foundation — which provides funds for translational biomedical research aimed at helping children — recently issued three grants and a fellowship to Cornell researchers. These funds, totaling $1 million, make Cornell the first research university to receive three faculty grants simultaneously from the foundation.
Undergrads Present at C.U. Research Board Forum
April 24, 2008 - 12:00amCornell is renowned for its various fields of research, which comes most prominently from the graduate community. However, as the spring undergraduate forum held by the Cornell University Research Board showcased last night, undergraduate research is also prevalent at C.U.
The forum featured presentations from undergraduates of all the colleges, each of whom had different motivations for being there.
Eric O’Hanon ’10, spoke about the danger of Bovine Growth Hormone, a hormone present in milk in American cows.
“I did this research for a class, and I figured this [forum] was the best way to present it to interested people,” he said, explaining his motivation for participating in the forum. “And, I just like talking to people,” he added
C.U. Researcher Critical of New HIV Treatment
October 11, 2007 - 12:00amA Cornell medical researcher has been vindicated in his claim that a recently-released HIV vaccine would be unsuccessful after the drug was pulled last month from the market in South Africa.
Dr. Kendall A. Smith of Cornell Weill Medical College explained that the leading pharmaceutical company Merck’s vaccine went on to Stage II testing in South Africa because “the vaccine had no adverse affects in Stage I.”
Smith described that testing the effectiveness of this and all HIV vaccines is so difficult because there is no animal model for HIV. While doctors do test some vaccines on monkeys, because they have SIV (which affects simians as opposed to humans) it is difficult to find matching cures.
Weill Cornell Research Findings Link Nicotine, Atherosclerosis
October 4, 2007 - 12:00amNearly 70.3 million Americans over 12 years of age used tobacco at least once a month in 2004 according to the National Institute on Drug Abuse. This statistic is of increasing concern, as findings recently published by researchers at Weill Cornell Medical College linked nicotine and atherosclerosis.
Nicotine, the addictive ingredient found in tobacco, stimulates reward pathways and releases certain neurotransmitters in the brain, according to the NIDA. These events lead to feelings of pleasure which shortly dissipate, creating a powerful addiction.
Not only is nicotine highly addictive, but it also presents other serious health risks.